IDEAYA Biosciences Inc. (IDYA)
NASDAQ
34.71
-1.41 (-3.90%)
Closed
Oct 23, 2026
Day's Range
34.5336.35
52 wk Range
26.8142.68
Financial Statements - IDYA - IDEAYA Biosciences Inc.
Revenue
218.71M▲ 3024.4%
Net Income
-113.69M▲ 58.6%Net Margin -52.0%
EBITDA
-154.72M▲ 52.1%
Free Cash Flow
-73.46M▲ 70.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 218.71M | 7M | 23.38M | 50.93M | 27.94M | 19.53M |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -159.31M | -326.97M | -134.42M | -62.50M | -50.26M | -35.34M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | -113.69M | -274.47M | -112.96M | -58.65M | -49.76M | -34.49M |
| Income Tax | - | - | - | - | - | - |
| Net Income | -113.69M | -274.47M | -112.96M | -58.65M | -49.76M | -34.49M |
| EPS Basic | -1.28 | -3.36 | -1.96 | -1.42 | -1.41 | -1.4 |
| EPS Diluted | -1.28 | -3.36 | -1.96 | -1.42 | -1.41 | -1.4 |
| Basic Shares Outstanding | 88.48M | 81.67M | 57.51M | 41.44M | 35.25M | 24.72M |
| Diluted Shares Outstanding | 88.48M | 81.67M | 57.51M | 41.44M | 35.25M | 24.72M |
| Ebit | -159.31M | -326.97M | -134.42M | -62.50M | -50.26M | -35.34M |
| Ebitda | -154.72M | -323.14M | -130.42M | -58.98M | -47.23M | -33.96M |
| Net Income Continuous Operations | -113.69M | -274.47M | -112.96M | -58.65M | -49.76M | -34.49M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | 2.15M | 719K | 58K |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
